Tagged with UHC UnitedHealthcare
In 2019, UnitedHealthcare (UHC) will be growing its national network of participating laboratory providers to better support members and the care providers who order laboratory services.
UnitedHealthcare (UHC) has released its most recent medical policy updates for November 2018 which includes complete details on UHC medical policy, medical benefit drug policy, coverage determination guideline), utilization review guideline, and/or quality of care guideline updates, as well as new, updated, revised, replaced and retired health services policies.
In November, UnitedHealthcare (UHC) will make changes to the way it manages prior authorization requests for certain outpatient injectable cancer therapy, including chemotherapy and biologic therapy, colony stimulating factors and denosumab.
Effective April 1, UnitedHealthcare (UHC) will require care providers to submit a notification for injectable chemotherapy for members located in Wisconsin when it is administrated in an outpatient setting for UHC Medicare Advantage (MA) members with a cancer diagnosis.
Connecticut, New Jersey, New York – Specialty Pharmacy Requirements for Certain Specialty Medications
UnitedHealthcare (UHC) will soon require Oxford Health Plan Commercial Members, participating hospitals in New York, New Jersey and Connecticut to purchase certain medications from a specialty pharmacy.
UnitedHealth Group has announced plans to introduce a new payment policy intended to reduce its emergency department claims cost.
UnitedHealthcare (UHC) has made changes to its reimbursement policy for Laboratory Services affecting reference laboratories and non-reference laboratory physicians.
As of March 1 for UnitedHealthcare (UHC) Medicare Advantage (MA) members in Florida and Georgia and April 1 for plans in Wisconsin, UHC will require care providers to submit a notification for injectable chemotherapy when administrated in an outpatient setting for UHC MA members with a cancer diagnosis.
For dates of service on or after April 1st, UnitedHealthcare is expanding notification/prior authorization requirements for certain services to be covered in certain sites of care to include commercial members in Indiana and New Jersey.
Effective for dates of service on or after April 1st, several new codes will be added to UHC’s prior authorization list as a result of the American Medical Association (AMA) 2018 annual CPT® update.
UHC has announced two updates for notification and prior authorization on certain procedures, as well as revisions to its emergency department facility evaluation and management (e/m) coding policies.
On March 1, 2018, UnitedHealthcare MA will require notification for injectable outpatient chemotherapy drugs given for a cancer diagnosis for members in Florida and Georgia.
UnitedHealthcare has released several policy and reimbursement updates that will take effect on December 1, 2017.
Beginning November 1, UnitedHealthcare (UHC) will require a new online notification/prior authorization process for genetic and molecular lab tests for their Commercial benefit plan members.
Effective Nov. 1, UnitedHealthcare will start its online prior authorization/notification program for genetic and molecular testing performed in an outpatient setting for fully insured UnitedHealthcare Commercial Plan members. Providers requesting laboratory testing will be required to complete the prior auth. process as well as indicate the laboratory and test name for specific services.
UnitedHealthcare Expands Prior-Authorization Requirement for Certain Office-Based Procedures Performed in Other Sites of Service
Beginning October 1, UnitedHealthcare will require notification/prior authorization for certain procedures when performed in any setting other than a physician’s office.
New York health insurers are seeking premium rate increases averaging 16.6% in the individual market and 11.5% in the small group market for 2018.
For the first time since 1990, the Illinois Department of Insurance will conduct a broad market examination of Blue Cross and Blue Shield of Illinois to see how the insurer treats its customers in compliance with consumer protection regulations.
OptumHealth, a subsidiary of UnitedHealthcare, has announced plans to acquire Reliant Medical Group, a physician group out of Massachusetts. The acquisition represents Optum’s first venture into the state’s provider market.
Health insurers in Connecticut have submitted health insurance rate request individual and small group plans in 2018. A total of 10 health insurance companies have made 14 filings on individual and small group plans that provide coverage to approximately 270,000 people in the state. The average rate requests range from 3.6% to 33.8%.